- Q3 revenue surged 141% year-over-year to $18.3 million.
- Bookings reached $24.1 million, with an effective backlog of $21.8 million.
- Aehr (AEHR, Financial) successfully diversified its business, with AI processors now comprising over 35% of revenue.
Aehr Test Systems (AEHR) reported a significant increase in revenue for Q3 fiscal 2025, reaching $18.3 million, compared to $7.6 million in the same period the previous fiscal year. Despite the notable revenue growth of 141% year-over-year, the company posted a GAAP net loss of $(0.6) million or $(0.02) per share, an improvement from the $(1.5) million loss reported last year. Non-GAAP net income stood at $2.0 million, showcasing a turnaround from a $(0.9) million loss the prior year.
The company's bookings for the quarter amounted to $24.1 million, while the backlog as of February 28, 2025, was reported at $18.2 million, with the effective backlog, including recent bookings, rising to $21.8 million. Aehr has strategically diversified its revenue streams, particularly notable is the shift in business composition, with Silicon Carbide wafer level burn-in (WLBI) decreasing from 90% to under 40% of their business, making room for AI processors, which now account for more than 35% of the revenue.
Despite the operational progress and diversification into AI processors and GaN power semiconductors, Aehr has temporarily withdrawn its fiscal 2025 guidance due to ongoing tariff uncertainties. The company emphasized that this decision is due to potential secondary effects on customer orders and supply chain issues stemming from new U.S. tariff announcements. As of the end of Q3 fiscal 2025, Aehr's cash reserves, including cash equivalents and restricted cash, totaled $31.4 million.
